Bioalpha signs MoU with Zuellig Pharma for vaccine distribution


KUALA LUMPUR: Bioalpha Holdings Bhd's subsidiary has entered a memorandum of understanding with Zuellig Pharma Sdn Bhd for the import and distribution of the Covid-19 vaccine in Malaysia.

It said in a filing with Bursa Malaysia that the contract shall be effective from Jan 22, 2021 and is subject to approval from the relevant authorities for the distirubtion and sale of the vaccine.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Bioalpha , Zuellig Pharma , vaccine

   

Next In Business News

Trading ideas: BHIC, Naza, F&N, Pestech, PetGas, XIX, TT Vision, Uzma, WTK, Ranhill, Farm Price, Sarawak Cable, SLP
Fed’s Williams says 2% inflation target ‘critical’
TD risks earnings hit from US probe
Promoting Techcombank as industry leader
EV maker Zeekr set to raise US$368mil from IPO
EV production keeps demand for copper high
New tea businesses bubble up toward a boom
United, American strike deal on US$8.5bil Chicago O’Hare airport revamp
Bursa Malaysia likely to trade range-bound with upside bias this week
RCE Cap to benefit from civil servant salary hike

Others Also Read